Characterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol)

Journal of Biomedical Nanotechnology

Volumn 5, Issue 2, 2009, Pages 202-208

  Sou, Keitaro ^a   Oyajobi, Babatunde O ^b   Goins, Beth ^c   Phillips, William T ^c   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Anticancer drug; Curcumin; Drug delivery; Micelles; Nanoparticles; Nanotechnology; Poly(ethylene glycol)

Indexed keywords

ANTICANCER DRUG; CANCER CELLS; CELL VIABILITY; CURCUMIN; CYTOTOXIC ACTIVITIES; DRUG DELIVERY SYSTEM; LIPOPHILIC DRUGS; MIXED ASSEMBLIES; MYELOMA CELL; NANO-SIZED; POLY(OXYETHYLENE) CHOLESTERYL ETHER; RAPID DECOMPOSITION; SELF-ORGANIZED;

CYTOTOXICITY; DRUG DELIVERY; ETHERS; ETHYLENE; ETHYLENE GLYCOL; MICELLES; NANOPARTICLES; NANOTECHNOLOGY; POLYETHYLENE OXIDES;

POLYETHYLENE GLYCOLS;

CM; CURCUMIN; MACROGOL; NANOPARTICLE; POLY(ETHYLENE)CHOLESTERYL ETHER NANOPARTICLE; SELF ASSEMBLED MONOLAYER; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG STABILITY; HUMAN; HUMAN CELL; HYDROLYSIS; HYDROPHOBICITY; IN VITRO STUDY; LIPOPHILICITY; LIQUID; MICELLE; MYELOMA CELL; NANOENCAPSULATION; PARTICLE SIZE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CRYSTALLIZATION; CURCUMIN; DRUG CARRIERS; HUMANS; HYDROPHOBICITY; MACROMOLECULAR SUBSTANCES; MATERIALS TESTING; MICE; MOLECULAR CONFORMATION; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES;

EID: 67649352996     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.1025     Document Type: Article

References (37)

1. J. M. Harris, Introduction to biotechnical and biomedical applications of poly(ethylene glycol). Poly-(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications, edited by J. M. Harris, Plenum Press, New York (1990), pp. 1-14.
2. K. Kataoka, A. Harada, and Y. Nagasaki, Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev. 47, 113 (2001).
3. S. Zalipsky, Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chem. 6, 150 (1995).
4. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang, Amphipatic poly(ethylene glycol)s effectively prolong the circulation time of liposome. FEBS Lett. 268, 235 (1990).
5. M. C. Woodle and D. D. Lasic, Sterically stabilized liposome. Biochim. Biophys. Acta 1113, 171 (1992).
6. T. Yuda, K. Maruyama, and M. Iwatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols. Biol. Pharm. Bull. 19, 1347 (1996).
7. W. T. Phillips, R. W. Klipper, V. D. Awasthi, A. R. Rudolph, R. Cliff, V. Kwasiborski, and B. A. Goins, Polyethylene glycolmodified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J. Pharmacol. Exp. Ther. 288, 665 (1999).
8. S. Takeoka, K. Mori, H. Ohkawa, K. Sou, and E. Tsuchida, Synthesis and assembly of poly(ethylene glycol)-lipids with mono-, di-, and tetraacyl chains and a poly(ethylene glycol) chain of various molecular weights. J. Am. Chem. Soc. 122, 7927 (2000).
9. M. Johnsson, P. Hansson, and K. Edwards, Spherical micelles and other self-assembled structures in dilute aqueous mixtures of poly(ethylene glycol) lipids. J. Phys. Chem. B 105, 8420 (2001).
10. T. Sato, M. D. K. Hossain, D. P. Acharya, O. Glatter, A. Chiba, and H. Kunieda, Phase behavior and self-organized structures in water/poly(oxyethylene) cholesteryl ether systems. J. Phys. Chem. B 108, 12927 (2004).
11. T. Sato, H. Sakai, K. Sou, R. Buchner, and E. Tsuchida, Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: Hydration, static structure, and interparticle interactions. J. Phys. Chem. B. 111, 1393 (2007).
12. V. P. Torchilin, PEG-micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 54, 235 (2002).
13. H. Wang, H. Önyüksel, A. Gulati, and I. Rubinstein, Self-association of endothelin-1 with sterically stabilized phospholipid nanomicelles amplifies its hemodynamic effects in rats. J. Biomed. Nanotechnol. 3, 270 (2007).
14. E. Kunchandy and M. N. A. Rao, Oxygen radical scavenging activity of curcumin. Int. J. Pharm. 58, 237 (1990).
15. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270, 24995 (1995).
16. R. A. Sharma, A. J. Gescher, and W. P. Steward, Curcumin: The story so far. Eur. J. Cancer 41, 1955 (2005).
17. A. L. Cheng, C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, W. Ming-Shiang, H. S. Yu, S. H. Jee, G. S. Chen, T. M. Chen, C. A. Chen, M. K. Lai, Y. S. Pu, M. H. Pan, Y. J. Wang, C. C. Tsai, and C. Y. Hsieh, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21, 2895 (2001).
18. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher, and W. P. Steward, Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer Res. 10, 6847 (2004).
19. L. Li, F. S. Braiteh, and R. Kurzrock, Liposome-encapsulated curcumin. In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322 (2005).
20. A. Kunwar, A. Barik, R. Pandey, and K. I. Priyadarsini, Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study. Biochim. Biophys. Acta 1760, 1513 (2006).
21. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337, 299 (2007).
22. K. Sou, S. Inenaga, S. Takeoka, and E. Tsuchida, Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm. 352, 287 (2008).
23. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel, Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res. A 86, 300 (2008).
24. A. Sahu, U. Bora, N. Kasoju, and P. Goswami, Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater. 4, 1752 (2008).
25. A. Sahu, N. Kasoju, and U. Bora, Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 9, 2905 (2008).
26. K. Sou, T. Endo, S. Takeoka, and E. Tsuchida, Polyethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjugate Chem. 11, 372 (2000).
27. Y. J. Wang, J. M. H. Pan, A. L. Cheng, L. I. Lin, Y. S. Ho, C. Y. Hsieh, and J. K. Lin, Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15, 1867 (1997).
28. M. H. Leung, H. Colangelo, and T. W. Kee, Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 24, 5672 (2008).
29. M. B. Yatvin, W. Kreutz, B. A. Horwitz, and M. Shinitzky, pH-sensitive liposomes: Possible clinical implications. Science 210, 1253 (1980).
30. D. C. Drummond, M. Zignani, and J. Leroux, Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 39, 409 (2000).
31. A. S. Hoffman, P. S. Stayton, M. E. H. El-Sayed, N. Murthy, V. Bulmus, C. Lackey, and C. Cheung, Design of "smart" nano-scale delivery systems for biomolecular therapeutics. J. Biomed. Nanotech. 3, 213 (2007).
32. S. V. Jovanovic, S. Steenken, C. W. Boone, and M. G. H. Simic, Atom transfer as a preferred antioxidant mechanism of curcumin. J. Am. Chem. Soc. 121, 9677 (1999).
33. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053 (2003).
34. Y. Teramura and H. Iwata, Islets surface modification prevents blood-mediated inflammatory responses. Bioconjugate Chem. 19, 1389 (2008).
35. K. Miyajima, T. Baba, and M. Nakagaki, Hemolytic activity of polyoxyethylene cholesteryl ethers. Colloid and Polymer Sci. 265, 943 (1987).
36. P. Maher and S. J. Singer, Structural changes in membranes produced by the binding of small amphipathic molecules. Biochemistry 23, 232 (1984).
37. M. N. Jones, Surfactants in membrane solubilisation. Int. J. Pharm. 177, 137 (1999).